Internal Medicine, Rheumatology · Trinity, FL
NPI
1518411602
Since 2016
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
9332 State Road 54 Ste 301
Trinity, FL, 34655
Phone (727) 940-9391
Groups this clinician bills Medicare through
Medicare paid, 2024
$643K
51,570 services
Medicare patients, 2024
346
Average age 73
Drug cost, 2024
$1.8M
2,296 prescriptions
Company payments, 2025
$57K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Monica Shah was code J3111 (injection, romosozumab-aqqg, 1 mg), 11,130 times for 13 patients. In total Monica Shah billed 51,570 services in 30 codes, and Medicare paid $643K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 11,130 | 13 | $8.58 | $95K |
| J0897 Injection, denosumab, 1 mg | Office | 4,020 | 45 | $20.69 | $83K |
| 99214 Office E&M - Established | Office | 492 | 267 | $86.79 | $43K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 219 | 182 | $12.81 | $2,805 |
| 96372 Injection Administration | Office | 114 | 47 | $10.82 | $1,233 |
| 96401 Chemotherapy Administration | Office | 113 | 32 | $53.56 | $6,052 |
| 96365 Intravenous Infusion, Hydration | Office | 100 | 20 | $46.34 | $4,634 |
| 99204 Office E&M - New | Office | 77 | 77 | $114.70 | $8,832 |
| 99213 Office E&M - Established | Office | 70 | 67 | $69.36 | $4,855 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 60 | 13 | $0.10 | $6.05 |
| 96413 Chemotherapy Administration | Office | 54 | 20 | $89.08 | $4,810 |
| 99203 Office E&M - New | Office | 17 | 17 | $86.81 | $1,476 |
By year: 2022 $107K for 4,738 services; 2023 $423K for 31,856 services; 2024 $643K for 51,570 services.
Medicare prescription drug claims, 2024
In 2024, the drug Monica Shah prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 210 prescriptions and refills. In total Monica Shah wrote 2,296 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 210 | 409 | 69 | $4,549 |
| Hydroxychloroquine Sulfate Generic | 199 | 483 | 78 | $8,229 |
| Duloxetine Hcl Generic | 190 | 449 | 60 | $4,468 |
| Prednisone Generic | 181 | 272 | 54 | $1,292 |
| Celecoxib Generic | 158 | 266 | 59 | $3,423 |
| Gabapentin Generic | 112 | 245 | 41 | $2,055 |
| Cyclobenzaprine Hcl Generic | 104 | 185 | 52 | $1,040 |
| Alendronate Sodium Generic | 84 | 162 | 21 | $460 |
| Leflunomide Generic | 82 | 177 | 29 | $2,761 |
| Tizanidine Hcl Generic | 62 | 132 | 29 | $709 |
| Tramadol Hcl Generic | 58 | 58 | 18 | $505 |
| Pregabalin Generic | 58 | 134 | 23 | $1,550 |
| Rinvoq Upadacitinib | 50 | 50 | 11 | $324K |
| Pilocarpine Hcl Generic | 44 | 66 | 11 | $2,743 |
| Meloxicam Generic | 39 | 109 | 24 | $182 |
Brand drugs: - claims; generic drugs: 1,980 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Monica Shah $57K ($57K in general payments such as food, travel and fees) from 19 companies. The largest payer was UCB, Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 65 | $32K |
| Janssen Biotech, Inc. JNJ | 26 | $16K |
| Genzyme Corporation SNY | 10 | $5,148 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $1,575 |
| Amgen Inc. AMGN | 25 | $701 |
| Abbvie Inc. ABBV | 21 | $666 |
| Mallinckrodt Hospital Products Inc. | 7 | $222 |
| Pfizer Inc. PFE | 6 | $125 |
| Radius Health, Inc. | 4 | $97.19 |
| GlaxoSmithKline, LLC. GSK | 3 | $78.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.